A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain
- PMID: 36477107
- PMCID: PMC9729199
- DOI: 10.1038/s41598-022-24719-z
A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain
Abstract
This study aimed to report mortality, risk factors, and burden of diseases in Spain. The Global Burden of Disease, Injuries, and Risk Factors 2019 estimates the burden due to 369 diseases, injuries, and impairments and 87 risk factors and risk factor combinations. Here, we detail the updated Spain 1990-2019 burden of disease estimates and project certain metrics up to 2030. In 2019, leading causes of death were ischaemic heart disease, stroke, chronic obstructive pulmonary disease, Alzheimer's disease, and lung cancer. Main causes of disability adjusted life years (DALYs) were ischaemic heart disease, diabetes, lung cancer, low back pain, and stroke. Leading DALYs risk factors included smoking, high body mass index, and high fasting plasma glucose. Spain scored 74/100 among all health-related Sustainable Development Goals (SDGs) indicators, ranking 20 of 195 countries and territories. We forecasted that by 2030, Spain would outpace Japan, the United States, and the European Union. Behavioural risk factors, such as smoking and poor diet, and environmental factors added a significant burden to the Spanish population's health in 2019. Monitoring these trends, particularly in light of COVID-19, is essential to prioritise interventions that will reduce the future burden of disease to meet population health and SDG commitments.
© 2022. The Author(s).
Conflict of interest statement
J.V.L. reports grants from AbbVie, Gilead Sciences, MSD, and Roche Diagnostics; consulting fees from NovoVax; payment or honoraria for lectures, presentations, speakers’ bureaus, and educational events from AbbVie, Gilead, Sciences, Intercept, and Janssen; participation on a Data Safety Monitoring Board with the QuickStart Study; and leadership, unpaid, with the EASL international Liver Foundation and HIV Outcomes; all outside the submitted work. A.O. reports (all outside the submitted work) grants from Sanofi and consultancy or speaker fees or travel support from Advicciene, Astellas, Astrazeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk, and Vifor Fresenius Medical Care Renal Pharma and is Director of the Catedra Mundipharma-UAM of diabetic kidney disease and the Catedra Astrazeneca-UAM of chronic kidney disease and electrolytes. All other authors declare no competing interests.
Figures






Similar articles
-
The burden of disease in Spain: Results from the Global Burden of Disease 2016.Med Clin (Barc). 2018 Sep 14;151(5):171-190. doi: 10.1016/j.medcli.2018.05.011. Epub 2018 Jul 20. Med Clin (Barc). 2018. PMID: 30037695 English, Spanish.
-
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24. Lancet. 2019. PMID: 31248666 Free PMC article.
-
The state of health in Pakistan and its provinces and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Glob Health. 2023 Feb;11(2):e229-e243. doi: 10.1016/S2214-109X(22)00497-1. Lancet Glob Health. 2023. PMID: 36669807 Free PMC article.
-
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16. Lancet Respir Med. 2021. PMID: 34411511 Free PMC article.
-
NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4.Lancet. 2020 Sep 26;396(10255):918-934. doi: 10.1016/S0140-6736(20)31761-X. Epub 2020 Sep 3. Lancet. 2020. PMID: 32891217 Free PMC article. Review.
Cited by
-
Epidemiological Situation of High-Prevalence Non-Communicable Diseases in Spain: A Systematic Review.J Clin Med. 2023 Nov 15;12(22):7109. doi: 10.3390/jcm12227109. J Clin Med. 2023. PMID: 38002721 Free PMC article. Review.
-
The Cantabria Cohort, a protocol for a population-based cohort in northern Spain.BMC Public Health. 2023 Dec 5;23(1):2429. doi: 10.1186/s12889-023-17318-8. BMC Public Health. 2023. PMID: 38053113 Free PMC article.
-
Age and sex as key determinants of multiple sclerosis incidence in Spain: a comprehensive analysis using the global burden of disease database (1990-2019).Neurol Sci. 2025 Mar;46(3):1277-1284. doi: 10.1007/s10072-024-07899-6. Epub 2024 Nov 30. Neurol Sci. 2025. PMID: 39613940
-
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2024 Oct 11;19:2273-2283. doi: 10.2147/COPD.S466563. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39416877 Free PMC article.
-
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014-2020.Appl Health Econ Health Policy. 2025 Sep;23(5):885-903. doi: 10.1007/s40258-025-00961-0. Epub 2025 Mar 26. Appl Health Econ Health Policy. 2025. PMID: 40140225 Free PMC article.
References
-
- Bernal, E. et al. Spain: Health system review. In Health Systems in Transition, Vol. 20 (2018). - PubMed
-
- Benach J, Friel S, Houweling T, et al. A Conceptual Framework for Action on the Social Determinants of Health. World Health Organization; 2010.